Reserve your spot today for the Satellite Breakfast Symposium
Managed Care Review BoardTM - An Analysis of Current and Emerging Therapies and Benefit Design Considerations for Psoriasis and Psoriatic Arthritis
at Eisenhower and Impact Education, LLC, in collaboration
with Postgraduate Institute for Medicine.
For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
6:30 AM - 8:30 AM PDT
Moscone West Convention Center
Room 3014-3016
San Francisco, CA
Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting is required.
AMCP Managed Care & Specialty Pharmacy Annual Meeting.
Suggested Pre-reading:
Don't miss the free, on-demand CE primer for this activity!
www.ImpactEdu.net/PsoriaticPrimer
- Assessing the clinical benefits of evolving treatment options for psoriasis and psoriatic arthritis in a managed care setting
- Current practice guidelines review
- Comparative effectiveness research (CER) for improved treatment decisions
- Pharmacoeconomic assessment of current and evolving psoriasis and psoriatic arthritis treatment options
- Maximizing value in a new era of health care reform
|
Diana Brixner, RPh, PhD, FAMCP Professor, Department of Pharmacotherapy University of Utah College of Pharmacy Executive Director, Outcomes Research Center Director of Outcomes, Program in Personalized Health Care University of Utah Health Sciences Center |
|
James Kenney, RPh, MBA Manager, Specialty and Pharmacy Contracts Harvard Pilgrim Health Care |
|
Philip Mease, MD Clinical Professor University of Washington School of Medicine Director, Rheumatology Clinical Research Division Swedish Medical Center |
|
Kenneth Schaecher, MD, FACP, CPC Medical Director Select Health |
|
Paul Yamauchi, MD, PhD Clinical Assistant Professor of Dermatology David Geffen School of Medicine at UCLA Adjunct Associate Professor John Wayne Cancer Institute Dermatology Institute & Skin Care Center, Inc. Clinical Science Institute |
The Managed Care Review BoardTM format features multi-specialty, multi-professional managed care, and clinical specialist faculty who collaborate on the review of the clinical data, current guidelines, and economic data of a specific class of therapeutics. It uniquely provides the audience with a review of important, relevant therapeutic category information and features peer-to-peer exchange between a diverse group of managed care and clinical specialist faculty contributors. This interactive program is designed to engage the faculty and audience to develop solutions for managed care professionals to implement within their own setting to improve outcomes for patients' psoriatic disease. This approach supports managed care pharmacists by enhancing the results of their own health care organization's systematic literature reviews and analyses.
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
- Analyze the available evidence-base for the treatment of psoriasis and psoriatic arthritis (PsA) in a true CER framework
- Assess current and emerging therapies for the treatment of psoriasis and PsA and cite their clinical trial data
- Address nonadherence factors associated with various therapies for psoriasis and PsA
- Integrate interventions to coordinate health plan and affiliated providers efforts in the health care reform era that will lead to better outcomes for patients with psoriasis and PsA
- Provide accurate and appropriate counsel as part of the managed care treatment team
Date and Time
Wednesday, April 20, 2016
6:30 AM - 8:30 AM PDT
Moscone West Convention Center
Room 3014-3016
San Francisco, CA
| 6:30 AM | Breakfast and Registration |
| 6:35 AM |
Pre-Activity Learning Assessment and Opening Comments |
| 6:40 AM |
Evolving Treatment Options and Clinical Benefits Update in Psoriasis and
Psoriatic Arthritis
Philip Mease, MD Paul Yamauchi, MD, PhD |
| 7:15 AM |
Current Practice Guidelines Review and Application of CER Analyses to
Improve Treatment Decisions
Kenneth Schaecher, MD, FACP, CPC |
| 7:35 AM |
Faculty Idea Exchange Faculty Panel |
| 7:40 AM |
Analyzing the Available Data to Assess the Value of Psoriasis and Psoriatic Arthritis Treatment Options Diana Brixner, RPh, PhD, FAMCP |
| 7:55 AM |
Plan Benefit Designs and Specialty Pharmacy Considerations in a New Era of Health Care Reform James Kenney, RPh, MBA |
| 8:15 AM |
Moderated Faculty Idea Exchange and Audience Q&A Closing Commentary, Post-Activity Assessment and Evaluation |
| 8:30 AM | Adjournment |
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Impact Education, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
Accreditation Statement
 |
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Credit Designation
This program has been assigned ACPE Universal Activity #0797-9999-16-023-L04-P. This program is designated for up to 2.0 contact hours (0.20 CEUs) of continuing pharmacy education credit.
Type of Activity: Knowledge
For Pharmacists: Upon receipt of a completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.
Fee Information
No additional fee is required to attend this CPE/CME activity.
Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting is required.
Pre-registration will close at 12:00 pm on April 19, 2016.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.
